21 . 05 .2018
Press release
Nestlé Skin Health Announces the FDA Approval of Restylane® Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
07 . 05 .2018
Press release
Galderma Announces Results of ALAMO: A Real-World, Phase 4 Study Demonstrating Efficacy and Safety of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Plus Oral Doxycycline 200 mg in Treating Severe Inflammatory Acne
30 . 04 .2018
Press release
New Phase 4 OSCAR Trial Data Showed that Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Decreased Acne Lesions Therefore Reducing the Risk of Scars in Moderate-to-Severe Acne Patients
21 . 02 .2018
Press release
Differin® Expands Portfolio with the Addition of Two New Facial Skincare Products
31 . 08 .2017
Press release
Nestlé Skin Health announces its intention to cease operations at its Egerkingen Factory
25 . 07 .2017
Press release
Galderma Announces Enrollment of First Patient in Phase IIb Nemolizumab Trial in Atopic Dermatitis